AIRBUS has delivered India’s first fully customised, ACH145 helicopter to Adar Poonawalla, CEO and executive director of Serum Institute of India, the world’s largest vaccine manufacturer by doses. This marks the entry of the highly successful twin-engine helicopter into India’s private and business aviation market. The helicopter will be ready to fly in India by the end of January.
“We are delighted with our selection of the Airbus ACH145 which is certainly a benchmark in its class. It has been chosen, keeping in mind the highest levels of customization, comfort, and safety. Also, Airbus Helicopters’ comprehensive local support system will ensure the optimal availability of the aircraft,” said Poonawalla.
“Airbus is the market leader in civil helicopters in India. Our VIP customers come to Airbus Helicopters for unparalleled quality and a bespoke experience,” said Anand E Stanley, president, and managing director, Airbus India & South Asia. “They rely on our products’ ability to combine state-of-the-art technology with new transportation possibilities.”
The helicopter provides a spacious cabin that can seat up to eight in ACH Line, ACH Mercedes Benz Style or ACH bespoke versions. The ACH145 features Airbus Helicopters’ Helionix increased maximum gross weight capability.
“The latest delivery proves once again that Airbus is the only original equipment maker which is able to offer helicopters embedding the highest levels of innovation and end-to-end solutions for the ease of operations of customers. The delivery of this helicopter is an important milestone for us,” said Ashish Saraf, head, Airbus Helicopters India & South Asia.